C12Y 504/02003
Phosphoacetylglucosamine mutase
Official title: Phosphoacetylglucosamine mutase (5.4.2.3)
C12Y504/02003 (Phosphoacetylglucosamine mutase) appears on 0 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 5
- Assignees
- 4
- Inventors
- 35
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
No granted patents in this class yet.
- Methods of Production of Heparosan, Heparan Sulfate and Heparin in Yeast18 Jun 2026US 2026/0168001 A1Genhtis Fine Chemicals GmbH
- Hyaluronic acid-producing recombinant cells8 May 2025US 2025/0146037 A1Givaudan SA
- Chondroitin-producing recombinant cell28 Nov 2024US 2024/0392335 A1Givaudan SA
- Extracellular production of glycosylated products5 Sep 2024US 2024/0294958 A1Inbiose N.V.
- Novel purified polypeptides from bacteria18 Aug 2005US 2005/0181388 A1Affinium Pharmaceuticals, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.